DocMorris AG (DOCM.SW)

CHF 20.44

(-13.17%)

Market Cap (In CHF)

283.71 Million

Revenue (In CHF)

969.46 Million

Net Income (In CHF)

82.28 Million

Avg. Volume

125.69 Thousand

Currency
CHF
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
19.34-101.6
PE
-
EPS
-
Beta Value
1.404
ISIN
CH0042615283
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Mr. Walter Hess
Employee Count
-
Website
https://corporate.docmorris.com/en
Ipo Date
2017-07-06
Details
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose Group AG and changed its name to DocMorris AG in May 2023. DocMorris AG was founded in 1993 and is headquartered in Frauenfeld, Switzerland.